XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Parent Company Financials.
6 Months Ended
Jun. 30, 2021
Condensed Financial Information Disclosure [Abstract]  
PARENT COMPANY FINANCIALS.
11.PARENT COMPANY FINANCIALS.

 

Restricted Net AssetsAt June 30, 2021, the Company had approximately $245.7 million of net assets at its subsidiaries that were not available for transfer to Alto Ingredients in the form of dividends, distributions, loans or advances due to restrictions contained in the credit facilities of these subsidiaries.

 

Parent company financial statements for the periods covered in this report are set forth below (in thousands):

 

   June 30,
2021
   December 31,
2020
 
ASSETS        
Current Assets:        
Cash and cash equivalents  $15,128   $25,632 
Receivables from subsidiaries   13,460    15,548 
Other current assets   2,588    1,836 
Total current assets   31,176    43,016 
           
Property and equipment, net   108    142 
Other Assets:          
Investments in subsidiaries   264,645    246,518 
Alto West, LLC receivable   27,592    42,649 
Right of use operating lease assets, net   2,844    2,985 
Other assets   796    1,088 
Total other assets   295,877    293,240 
Total Assets  $327,161   $336,398 
Current Liabilities:          
Accounts payable and accrued liabilities  $5,439   $2,001 
Accrued Alto Op Co. purchase   3,829    3,829 
Current portion of long-term debt   6,696    25,533 
Other current liabilities   329    473 
Total current liabilities   16,293    31,836 
           
Long-term debt, net of current portion   
    5,564 
Other liabilities   2,849    2,763 
Total Liabilities   19,142    40,163 
Stockholders’ Equity:          
Preferred stock   1    1 
Common and non-voting common stock   73    72 
Additional paid-in capital   1,035,980    1,036,638 
Accumulated other comprehensive loss   (3,878)   (3,878)
Accumulated deficit   (724,157)   (736,598)
Total Alto Ingredients, Inc. stockholders’ equity   308,019    296,235 
Total Liabilities and Stockholders’ Equity  $327,161   $336,398 

  

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2021   2020   2021   2020 
                 
Management fees from subsidiaries  $2,486   $2,873   $5,012   $6,126 
Selling, general and administrative expenses   4,393    4,308    9,044    9,685 
Income (loss) from operations   (1,907)   (1,435)   (4,032)   (3,559)
Fair value adjustments   
    (1,314)   
    (641)
Interest expense, net   (704)   (1,721)   (1,731)   (3,297)
Other income (expense)   410    (140)   1,218    (162)
Loss before benefit for income taxes   (2,201)   (4,610)   (4,545)   (7,659)
Benefit for income taxes   
    
    
    
 
Net loss   (2,201)   (4,610)   (4,545)   (7,659)
Equity in income (losses) of subsidiaries   10,591    19,574    17,613    (2,477)
Net income (loss) attributed to Alto Ingredients, Inc.  $8,390   $14,964   $13,068   $(10,136)

 

   For the Six Months Ended
June 30,
 
   2021   2020 
Operating Activities:        
Net income (loss)  $13,068   $(10,136)
Adjustments to reconcile net income (loss) to cash used in operating activities:          
Equity in (income) losses of subsidiaries   (17,613)   2,477 
Fair value adjustments   
    (641)
Depreciation   33    67 
Amortization of debt (premiums) discounts   409    (115)
Changes in operating assets and liabilities:          
Accounts receivable   2,088    (1,207)
Other assets   (319)   714 
Accounts payable and accrued expenses   (2,416)   
 
Accounts payable with subsidiaries   37    475 
Net cash used in operating activities   (4,713)   (8,366)
Investing Activities:          
Additions to property and equipment   
    
 
Net cash used in investing activities   
    
 
Financing Activities:          
Proceeds from issuances of common stock   462    282 
Proceeds from plant receivables   15,057    5,813 
Proceeds from long-term debt   
    5,973 
Payments on senior notes   (24,810)   
 
Dividend from subsidiary   3,500    
 
Net cash provided by (used in) financing activities   (5,791)   12,068 
Net change in cash and cash equivalents   (10,504)   3,702 
Cash and cash equivalents at beginning of period   25,632    4,985 
Cash and cash equivalents at end of period  $15,128   $8,687